Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney

Search this Article

Author(s)

    • SHIMIZU Kazuaki
    • Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
    • FURUICHI Kengo
    • Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
    • SAKAI Norihiko
    • Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
    • KITAGAWA Kiyoki
    • Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
    • MATSUSHIMA Kouji
    • Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo
    • MUKAIDA Naofumi
    • Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University
    • KANEKO Shuichi
    • Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
    • WADA Takashi
    • Department of Laboratory Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University

Journal

  • Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension

    Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension 34(6), 747-752, 2011-06-01

References:  24

Codes

  • NII Article ID (NAID)
    10031163247
  • NII NACSIS-CAT ID (NCID)
    AA10847079
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    09169636
  • Data Source
    CJP 
Page Top